About Frederic Guerard
Frederic Guerard is a president and chief executive officer, director at Qlaris Bio.
Form D filings also name Frederic Guerard as a director at Spiral Therapeutics and Lenz Therapeutics.
Frederic Guerard reports to the SEC as a director or officer of 2 public companies: CalciMedica (CALC) and LENZ Therapeutics (LENZ).
Frederic Guerard first appears on SEC filings in 2020.
Experience
This experience comes from Frederic Guerard's profile and from SEC filings. For roles taken from filings, the years are when the filings name Frederic Guerard in the role, so the role may have started earlier or lasted longer.
Qlaris Bio, Inc. Current
President and Chief Executive Officer, director
2026 – Present · Dedham, MA
Develops glaucoma treatments for patients with the eye disease.
Spiral Therapeutics Inc Current
Non-Executive Director
2023 – Present · South San Francisco, CA
Develops drug treatments for people with inner ear disorders.
CI
CalciMedica, Inc. Current
Chief Executive Officer and director
Non-Executive Director (2023 – Present)
2020 – Present · Public company (CALC)
OP
Opthea
Chief Executive Officer
2023 – 2025
GI
Graybug Vision, Inc.
Chief Executive Officer
2019 – 2023
NO
Novartis
Worldwide Business Franchise head Ophthalmology (2004 – 2019)
Head of Export Business Unit (1999 – 2004)
1999 – 2019
AC
Alcon, a Novartis company
Global Franchise Head Pharmaceuticals
2015 – 2016
TA
The Association of the British Pharmaceutical Industry (ABPI)
Board Member
2013 – 2015
MA
Medicines Australia
Board Member
2009 – 2012
SE
Servier
Product Manager
1997 – 1999
Key Colleagues at Startups
The people Frederic Guerard works with at each company, as listed on that company's latest Form D.
Qlaris Bio, Inc. · Form D, Jun 17, 2026
BW
Barbara Wirostko
Executive officer
AG
Adrienne Graves
Director
WH
Wende Hutton
Director
RW
Robert Warner
Director
RH
Ronald Hunt
Director
AD
Andrew Danielson
Director
Spiral Therapeutics Inc · Form D, Apr 16, 2026
WT
Warren Thaler
Director
Eugene De Juan
Executive Chairman
Anthony Adamis
Independent and director
Jean-Frederic Paulsen
Ferring Ventures SA and director
GG
Guy Jean Savoir Garcia
Director
Hugo Peris
Founder & CEO, director
Diamantis Xylas
Catalio Capital and director
Angela Macfarlane
Independent and director
Lenz Therapeutics, Inc. · Form D, Mar 10, 2023
ES
Evert Schimmelpennink
President & CEO, director
JM
James McCollum
Director
CO
Clare Ozawa
Director
ZS
Zach Scheiner
Director
SL
Stefan Larson
Director
Chris Dimitropoulos
Director